Defiance Large Cap ex-Mag 7 ETF (XMAG)

The Defiance Large Cap ex-Mag 7 ETF (ticker XMAG) is an exchange-traded fund that gives investors exposure to large-cap US companies while intentionally excluding Apple, Microsoft, Google (Alphabet), Amazon, Tesla, NVIDIA, and Meta — the group commonly called the Magnificent Seven. It exists to solve a specific and real problem: as of recent years, those seven companies have come to represent an enormous share of the total returns in broad US stock indices, leaving investors who buy a traditional index fund heavily concentrated in a narrow set of megacap tech stocks whether they intended to be or not.

What makes XMAG different from a standard large-cap index?

A traditional large-cap index like the S&P 500 holds roughly 500 companies, but because indices are weighted by market capitalization, the largest companies dominate. The Magnificent Seven — Apple, Microsoft, Alphabet, Amazon, Tesla, NVIDIA, and Meta — collectively make up a significant portion of the index, enough that owning the S&P 500 is increasingly a bet on those seven stocks’ continued dominance rather than a diversified bet across American large-cap business.

XMAG sidesteps that concentration by excluding those seven companies entirely. Everything else in the large-cap universe stays in the portfolio. The fund tracks the Fount Large Cap ex-Magnificent 7 Index, which follows the same fundamental membership rules as traditional large-cap indices — minimum market cap, trading volume, US listing — but with the Mag 7 removed before the index is calculated. That creates a different return profile: XMAG will outperform if those seven companies underperform their historical norms, and will lag if they continue to drive market returns. The exclusion is not a judgment about those companies’ quality, but a mechanical statement: do not let those seven names dominate my portfolio.

Who might buy this, and what are the trade-offs?

XMAG appeals to investors who believe that concentration in Magnificent Seven names has become excessive, and who want large-cap equity exposure without that specific concentration risk. It may also attract thematic or tactical investors who temporarily want underweight to tech mega-cap, or who simply prefer the discipline of knowing their portfolio will never hold more than a small slice of any single company.

The trade-off is real, though. If the Magnificent Seven continue to outperform the broader market — as they have done repeatedly — XMAG will drag behind a standard large-cap index fund. The exclusion is also static: it remains those exact seven companies, so if one of them falls in market cap and a newcomer rises into the Mag 7 ranking, XMAG will still exclude the former and still include the latter, creating small anomalies. Finally, because XMAG is smaller and less frequently traded than the S&P 500 itself, its expense ratio and spreads will be higher than the cheapest broad-market alternatives, an ongoing drag on long-term returns.

How does it track and what does it cost?

XMAG tracks the Fount Large Cap ex-Magnificent 7 Index, which is reconstituted and rebalanced on a regular schedule to maintain membership rules. Because the fund is carefully curated to exclude specific names rather than random, tracking error is typically low relative to its index, though not zero — there are always small discrepancies between what a fund holds and what its index says it should.

The expense ratio is quoted on the fund’s fact sheet and generally sits in the single-digit basis point range — competitive with other factor or thematic equity ETFs, though notably higher than the cheapest broad large-cap alternatives, which often charge 0.03 percent or less. The fund trades on a major US exchange with sufficient volume to trade near net asset value during normal market hours, though during volatile or low-volume periods spreads can widen.

Real risks: tracking error, opportunity cost, and definition creep

The clearest risk is opportunity cost. If the Magnificent Seven continue to lead the market for another five or ten years, XMAG will simply underperform, and that gap will compound. There is no way to know in advance whether the exclusion was wise.

A second concern is definition. The Mag 7 is not an official index membership rule; it is a colloquial term that financial media and investors agree on for those seven companies. Defiance has fixed the membership based on that agreement at a point in time, but if the composition of “what investors mean by Magnificent Seven” drifts, XMAG’s exclusion list will no longer be what people expect. This is not a flaw in the fund, but a reminder that thematic or categorical exclusions depend on stable, agreed-on definitions.

Finally, there is an implicit risk of index arbitrage. If the Magnificent Seven fall sharply in value, they might still be excluded from XMAG even if they no longer represent a concentration threat, and conversely, other large-cap stocks might grow into positions where concentration becomes relevant to an XMAG holder. The fund solves a real problem but not a permanent one; it is a tool for a particular moment in market structure, not a permanent solution.

How to research XMAG

Start with the fund’s fact sheet and prospectus from Defiance’s website, which explain the exact index methodology, holdings, and fees. The Fount Large Cap ex-Magnificent 7 Index documentation (available from the index provider) spells out membership rules and the reconstitution schedule. Compare XMAG’s holdings and performance against a standard large-cap ETF like an S&P 500 fund to see the real-world difference the Magnificent Seven exclusion makes. Look at recent returns in both up and down markets — does XMAG’s pattern differ in ways you expect, or does it reveal something about the Mag 7’s volatility or cyclicality? And verify the daily trading volume and bid-ask spread on your brokerage platform to confirm the fund is liquid enough for your account size.